Market Cap | 431.43B | P/E | 72.14 | EPS this Y | 159.70% | Ern Qtrly Grth | 68.30% |
Income | 7.34B | Forward P/E | 42.44 | EPS next Y | 40.30% | 50D Avg Chg | 1.00% |
Sales | 38.92B | PEG | 0.74 | EPS past 5Y | -1.53% | 200D Avg Chg | 19.00% |
Dividend | 1.00% | Price/Book | 36.52 | EPS next 5Y | 72.95% | 52W High Chg | -3.00% |
Recommedations | 2.00 | Quick Ratio | 0.60 | Shares Outstanding | 0.90B | 52W Low Chg | 53.00% |
Insider Own | 0.15% | ROA | 13.70% | Shares Float | 898.30M | Beta | 0.42 |
Inst Own | 83.50% | ROE | 59.25% | Shares Shorted/Prior | 6.58M/6.30M | Price | 454.48 |
Gross Margin | 80.75% | Profit Margin | 18.86% | Avg. Volume | 2,662,108 | Target Price | 1,003.35 |
Oper. Margin | 39.09% | Earnings Date | Oct 30 | Volume | 2,365,805 | Change | 0.31% |
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company operates Lilly Seaport Innovation Center (LSC), a research and development facility in the Boston Seaport to advancing Lilly's efforts in RNA and DNA-based therapies as well as discovering new drug targets to create life-changing medicines across several disease states, including diabetes, obesity, cardiovascular diseases, neurodegeneration, and chronic pain. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd, as well as development collaboration with Eli Lilly and Company for developing QIAstat-Dx IVD panel, for the detection of various APOE genotypes. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Cantor Fitzgerald | Overweight | Sep 16, 24 |
JP Morgan | Overweight | Sep 13, 24 |
Cantor Fitzgerald | Overweight | Sep 9, 24 |
Morgan Stanley | Overweight | Aug 27, 24 |
Cantor Fitzgerald | Overweight | Aug 19, 24 |
Guggenheim | Buy | Aug 16, 24 |
Berenberg | Buy | Aug 14, 24 |
Deutsche Bank | Buy | Aug 12, 24 |
Wells Fargo | Overweight | Aug 9, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
LILLY ENDOWMENT INC | Director Director | Jan 16 | Sell | 645.86 | 1,180 | 762,115 | 99,542,630 | 01/17/24 |
LILLY ENDOWMENT INC | Director Director | Jan 04 | Sell | 630.65 | 14,388 | 9,073,792 | 99,754,422 | 01/05/24 |
LILLY ENDOWMENT INC | Director Director | Aug 08 | Sell | 521.62 | 204,409 | 106,623,823 | 100,823,810 | 08/09/23 |
LILLY ENDOWMENT INC | Director Director | Jul 21 | Sell | 466.621 | 591 | 275,773 | 101,028,219 | 07/24/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 29 | Sell | 465.083 | 44,115 | 20,517,137 | 101,192,935 | 06/30/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 22 | Sell | 458.99 | 107,022 | 49,122,028 | 101,248,810 | 06/23/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 21 | Sell | 454.54 | 31,454 | 14,297,101 | 101,355,832 | 06/22/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 15 | Sell | 454.59 | 27,353 | 12,434,400 | 101,446,457 | 06/16/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 19 | Sell | 444.92 | 194,354 | 86,471,982 | 101,473,810 | 05/22/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 06 | Sell | 367.21 | 130,297 | 47,846,361 | 102,133,810 | 04/07/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 05 | Sell | 363.72 | 69,703 | 25,352,375 | 102,264,107 | 04/06/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 31 | Sell | 342.71 | 205,000 | 70,255,550 | 102,543,810 | 04/03/23 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Dec 02 | Sell | 372.97 | 49,089 | 18,308,724 | 102,948,810 | 12/05/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Dec 01 | Sell | 373.31 | 160,911 | 60,069,685 | 102,997,899 | 12/02/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Nov 07 | Sell | 364.42 | 63,585 | 23,171,646 | 103,158,810 | 11/08/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Nov 02 | Sell | 362.07 | 6,131 | 2,219,851 | 103,357,679 | 11/03/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Oct 18 | Sell | 334.29 | 12,042 | 4,025,520 | 103,529,293 | 10/19/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Oct 14 | Sell | 334.42 | 3,187 | 1,065,797 | 103,620,959 | 10/17/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Oct 06 | Sell | 336.56 | 149,264 | 50,236,292 | 103,624,546 | 10/07/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Sep 28 | Sell | 336.99 | 101,631 | 34,248,631 | 103,773,810 | 09/29/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jul 28 | Sell | 333.18 | 89,458 | 29,805,616 | 103,875,441 | 07/29/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jul 26 | Sell | 332.524 | 1,601 | 532,371 | 103,964,899 | 07/27/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jul 15 | Sell | 334 | 17,310 | 5,781,540 | 103,966,500 | 07/18/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jul 06 | Sell | 330.88 | 177,243 | 58,646,164 | 103,983,810 | 07/07/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 28 | Sell | 329.01 | 900 | 296,109 | 104,161,053 | 06/29/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 27 | Sell | 329.045 | 41,857 | 13,772,837 | 104,161,953 | 06/28/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 24 | Sell | 323.95 | 215,000 | 69,649,250 | 104,203,810 | 06/27/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 23 | Sell | 311.37 | 205,000 | 63,830,850 | 104,418,810 | 06/24/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 22 | Sell | 307.35 | 210,000 | 64,543,500 | 104,623,810 | 06/23/22 |
Zakrowski Donald A | Chief Accounting Off.. Chief Accounting Officer | Jun 01 | Sell | 313.44 | 1,000 | 313,440 | 6,274 | 06/02/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 25 | Sell | 309.36 | 41,610 | 12,872,470 | 105,212,200 | 05/26/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 24 | Sell | 306.01 | 100,000 | 30,601,000 | 105,253,810 | 05/25/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 23 | Sell | 303.37 | 118,856 | 36,057,345 | 105,353,810 | 05/24/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 18 | Sell | 302.00 | 700 | 211,400 | 105,472,666 | 05/19/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 17 | Sell | 302.73 | 19,683 | 5,958,635 | 105,473,366 | 05/18/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 16 | Sell | 302.75 | 80,761 | 24,450,393 | 105,493,049 | 05/17/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 08 | Sell | 310.88 | 139,045 | 43,226,310 | 105,573,810 | 04/11/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 06 | Sell | 301.11 | 51,851 | 15,612,855 | 105,783,810 | 04/07/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 05 | Sell | 294.4 | 113,756 | 33,489,766 | 105,835,661 | 04/06/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 04 | Sell | 293.152 | 39,393 | 11,548,137 | 105,949,417 | 04/05/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 30 | Sell | 292.03 | 2,500 | 730,075 | 106,154,186 | 03/31/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 28 | Sell | 292.155 | 7,538 | 2,202,264 | 106,161,027 | 03/29/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 18 | Sell | 288.4 | 210,000 | 60,564,000 | 106,203,810 | 03/21/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 17 | Sell | 283.95 | 220,000 | 62,469,000 | 106,413,810 | 03/18/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 15 | Sell | 273.77 | 220,075 | 60,249,933 | 106,633,810 | 03/16/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 14 | Sell | 269.73 | 173,085 | 46,686,217 | 106,853,885 | 03/15/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 11 | Sell | 269.047 | 21,840 | 5,875,986 | 107,026,970 | 03/14/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 10 | Sell | 266.8 | 184,982 | 49,353,198 | 107,048,810 | 03/11/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 09 | Sell | 266.94 | 20,018 | 5,343,605 | 107,233,792 | 03/10/22 |
Runge Marschall S | Director Director | Mar 01 | Buy | 246.78 | 202 | 49,850 | 15,436 | 03/07/22 |